Loading...
XSHG603309
Market cap447mUSD
Jan 09, Last price  
11.29CNY
1D
-0.96%
1Q
-3.26%
Jan 2017
-42.01%
IPO
20.30%
Name

Well Lead Medical Co Ltd

Chart & Performance

D1W1MN
XSHG:603309 chart
P/E
17.06
P/S
2.39
EPS
0.66
Div Yield, %
3.25%
Shrs. gr., 5y
2.51%
Rev. gr., 5y
12.96%
Revenues
1.37b
+0.63%
348,235,226387,220,714437,167,108496,414,401548,871,062515,419,906629,894,884745,834,592993,812,5561,130,678,8091,118,570,9381,363,352,5541,371,925,673
Net income
192m
+15.56%
47,924,93155,609,39963,585,72667,819,98091,324,89879,249,98264,557,09165,403,009121,144,863153,110,853106,093,288166,571,286192,485,118
CFO
234m
-40.30%
44,075,92783,234,11372,853,113107,343,45181,466,12385,348,01574,343,82889,888,862178,794,590228,443,989187,283,077391,125,593233,512,282
Dividend
May 23, 20240.5 CNY/sh
Earnings
May 09, 2025

Profile

Well Lead Medical Co., Ltd. engages in the research, production, and sale of medical catheters in anaesthesia, urology, respiratory, and hemodialysis areas. It also provides drainage suction nutrition products. Its products are used in hospitals, in division operations, therapies, and emergency and clinical care areas. The company markets and sells its products in China, North America, Europe, and Japan. Well Lead Medical Co., Ltd. was founded in 2004 and is headquartered in Guangzhou, China.
URL
http://www.welllead.com.cn/
IPO date
Mar 02, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,371,926
0.63%
1,363,353
21.88%
Cost of revenue
943,968
1,039,785
Unusual Expense (Income)
NOPBT
427,957
323,567
NOPBT Margin
31.19%
23.73%
Operating Taxes
32,700
27,900
Tax Rate
7.64%
8.62%
NOPAT
395,258
295,667
Net income
192,485
15.56%
166,571
57.00%
Dividends
(106,836)
(39,584)
Dividend yield
2.57%
0.68%
Proceeds from repurchase of equity
(1,061)
BB yield
0.03%
Debt
Debt current
90,073
122,969
Long-term debt
315,035
169,629
Deferred revenue
18,812
18,538
Other long-term liabilities
28,812
1
Net debt
(320,958)
(411,360)
Cash flow
Cash from operating activities
233,512
391,126
CAPEX
(357,886)
Cash from investing activities
(335,450)
Cash from financing activities
11,660
FCF
102,125
344,993
Balance
Cash
446,951
703,959
Long term investments
279,115
Excess cash
657,470
635,791
Stockholders' equity
1,109,233
1,108,955
Invested Capital
1,585,172
1,357,177
ROIC
26.87%
22.82%
ROCE
18.99%
16.15%
EV
Common stock shares outstanding
291,644
289,632
Price
14.23
-28.78%
19.98
26.22%
Market cap
4,150,096
-28.28%
5,786,852
40.60%
EV
3,848,956
5,391,385
EBITDA
500,125
389,087
EV/EBITDA
7.70
13.86
Interest
9,124
7,867
Interest/NOPBT
2.13%
2.43%